St. Racheal Pharma to Conduct Surveillance of Antibiotics Resistance in Nigeria

St. Racheal Pharma to Conduct Surveillance of Antibiotics Resistance in Nigeria

Due to

the increasing rate of antibiotic resistance in Nigeria, leading antibiotic manufacturers and marketers, St Racheal’s Pharma has stated that it would be conducting Surveillance of Antibiotic Resistance (SOAR) in Nigeria. This was made known at a media briefing to mark the 2018 World Antibiotic Awareness Week, the Chief Executive Officer, St Racheal’s Pharma, Mr. Akinjide Adeosun, said the study, which will be conducted in 2019, will provide doctors with current antibiotic sensitivity pattern, as well as guide them towards rational prescription of the drugs.

He said, “This will promote better treatment outcome for patients and peace of mind for doctors and pharmacists, and will on the long run help in curbing antibiotic resistance in the country. The World Health Organization (WHO) defines the right to health as the enjoyment of the highest attainable standard of health. This fundamental human right could be breached if we do not preserve the potency of the antibiotics we have today.”

He listed some causes of treatment failure in Nigeria to include wrong diagnosis and misapplication of antibiotics by quacks, lack of hygiene and poor sanitation by patients, under-dose of antibiotics by patients with correct diagnosis, counterfeit antibiotics by unscrupulous pharmaceutical manufacturers, among others.

He said, “To tackle the menace of antibiotic resistance in Nigeria, we advise members of the public to always consult their doctors and take prescriptions to pharmacists. Nigerians should stop self-medication and ensure they take the full dose of their antibiotics when prescribed by doctors.” He also advised doctors and pharmacists to always source their antibiotics from top quality pharmaceutical manufacturers while also calling on the industry to invest more towards the discovery of new antibiotics.

Leave a Reply

Your email address will not be published. Required fields are marked *